Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationHematopoiesisMice, Inbred C57BLRecurrenceCombined Modality TherapyRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteBone Marrow ExaminationImmunosuppressive AgentsRemission InductionTreatment OutcomeTime FactorsHematologic NeoplasmsGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingHepatic Veno-Occlusive DiseaseBone Marrow NeoplasmsTransplantation ImmunologyLeukemia, MyeloidGraft vs Host ReactionStem Cell TransplantationImmunosuppressionLymphocyte DepletionLeukocyte TransfusionLymphoma, Non-HodgkinHeart TransplantationAcute DiseaseT-LymphocytesColony-Forming Units AssaySevere Combined ImmunodeficiencyChimeraHLA AntigensMyelodysplastic SyndromesSurvival AnalysisRetrospective StudiesLung TransplantationCell DifferentiationCyclosporineBone DensityActuarial AnalysisHematologic DiseasesLymphocyte TransfusionNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsCarmustineOrgan TransplantationProtein PrecursorsPancytopeniaGraft vs Tumor EffectFollow-Up StudiesGraft vs Leukemia EffectLeukocyte CountCytarabineSpleenSurvival RateCytomegalovirus InfectionsBone ResorptionCells, CulturedMice, Inbred BALB CGranulocyte Colony-Stimulating FactorFlow CytometryMelphalanDisease-Free SurvivalEtoposideLymphomaMultiple MyelomaMice, KnockoutAntigens, CD34Fatal OutcomeHodgkin DiseaseCell TransplantationGranulocytesPrognosisInfection